Key Statistics for CEVI
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (SEK) (ttm)
|Est. EPS (SEK) (12/2013)
|Est. PEG Ratio
|Market Cap (M SEK)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (SEK)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CEVI
- Net Income (M/SEK)
CellaVision AB develops software products and hardware platforms which are used for fast blood analyses and diagnosis. The Company markets the DiffMaster and MICRO21 systems which locates, identifies, and classifies blood cells by means of automatic microscopy. Cellavision sells to laboratories in Europe and the United States. The Company operates an Internet based reference library.
More Company Profile & Key Executives for CEVI
|Lars GatenbeckChairman||Yvonne MartenssonPresident/CEO|
|Magnus BlixtChief Financial Officer||Stefan BengtssonChief Operating Officer|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.